Dietary carnitine proved to be an effective hypolipidemic agent
The choice is clear: Should GLP-1 originators maintain a dual-brand strategy, which allows for premium pricing in the self-pay weight management segment while enabling reimbursement for Type 2 diabetes, but also requires greater investment in brand differentiation and market education
Kadowaki T, Isendahl J, Khalid U, Lee SY, Nishida T, Ogawa W, et al
The mechanisms gut dysbiosis, immune dysregulation, endothelial damage, mitochondrial dysfunction are well-characterised
Human data are limited and mixed: Clinical studies have largely assessed safety and metabolism, while weight-related outcomes were modest and inconsistent
Regulation of cellular senescence via the FOXO4-p53 axis